Search Results - "Kumar, B. S. Ajai"

Screening for EGFR mutations in lung cancer, a report from India by Sahoo, Rashmita, V, Vidya Harini, Babu, V. Chitti, V. Patil Okaly, Geeta, Rao, Smitha, Nargund, Ashwini, Venkataswamy, E, Rao, Raghavendra, Kumar, B.S. Ajai

“…Abstract Epidermal growth factor receptor (EGFR) is one of the targeted molecular markers in many cancers including the lung malignancy. Genetic modifications…”
Get full text

Epidermal growth factor receptor mutation in non-small-cell lung carcinomas: A retrospective analysis of 1036 lung cancer specimens from a network of tertiary cancer care centers in India by Veldore, V, Rao, R, Kakara, S, Pattanayak, S, Tejaswi, R, Sahoo, R, Venkataswamy, E, Prabhudesai, S, Krishnamoorthy, N, Tejaswini, B, Hazarika, D, Gangoli, S, Rahman, S, Naik, R, Diwakar, R, Satheesh, C, Shashidhar, S, Patil, Shekar, Ajai Kumar, B

“…Background: Epidermal growth factor receptor (EGFR) mutation plays a vital role in the prognosis of patients with lung cancer. However, there is a dearth of…”
Get full text

Gold fiducial tracking using CyberKnife in adrenal metastasis from small cell lung cancers by Lohith, G., Ajai Kumar, B.S.

Get full text

Genomic profiling in a homogeneous molecular subtype of non-small cell lung cancer: An effort to explore new drug targets by Veldore, Vidya H, Patil, S, Satheesh, C T, Shashidhara, H P, Tejaswi, R, Prabhudesai, Shilpa A, Krishnamoorthy, N, Hazarika, D, Naik, R, Rao, Raghavendra M, Ajai Kumar, B S

“…Patients' who are positive for kinase domain activating mutations in epidermal growth factor receptor (EGFR) gene, constitute 30-40% of non-small cell lung…”
Get full text

Targeted Therapy Management in NSCLC Patients Using Cytology: Experience from a Tertiary Care Cancer Center by Veldore, Vidya H., Patil, Shekar, Prabhudesai, Shilpa, Satheesh, C. T., Shashidhara, H. P., Krishnamoorthy, Naveen, Hazarika, D., Tejaswi, R., Prabhudev, Ankita, Naik, Radheshyam, Rao, Raghavendra M., Kumar, B. S. Ajai

“…Background Although biopsy is the gold standard for diagnosis, cytological material has often been used to assist in making a pathologic diagnosis as well as…”
Get full text

541PGold fiducial tracking using CyberKnife in adrenal metastasis from small cell lung cancers by Lohith, G, Ajai Kumar, B S

Get full text

Prevalence of KRAS mutations in metastatic colorectal cancer: A retrospective observational study from India by Veldore, V H, Rao, M R, Prabhudesai, S A, Tejaswi, R, Kakara, S, Pattanayak, S, Krishnamoorthy, N, Tejaswini, B N, Hazarika, D, Gangoli, A, Rahman, S M, Dixit, J, Naik, R, Diwakar, R B, Satheesh, C T, Shashidhara, H P, Patil, S, Gopinath, K S, Kumar, B S

“…One of the genetic alterations implicated in tumor progression in colorectal cancers (CRCs) are abnormalities in Kristen Rat Sarcoma (KRAS) gene. Evaluation of…”
Get full text